Figure 5.
Frequencies of p540 peptide–specific CTLp's in cancer patients. The graphs show the frequency of p540 peptide–specific CTLp's from patients 9 (A) and 14 (B), representative of the 2 groups of cancer patients with low and high frequencies of hTERT-specific CTLp's, respectively.